BCC
AMED

Bridge City Capital’s Amedisys AMED Stock Holding History

Bridge City Capital’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-34,455
Closed -$3.39M – 109
2025
Q2 		$3.39M Sell
34,455
-492
-1% -$46.6K 0.95% 41
2025
Q1 		$3.24M Buy
34,947
+417
+1% +$38.4K 0.97% 43
2024
Q4 		$3.13M Sell
34,530
-361
-1% -$33.2K 0.84% 50
2024
Q3 		$3.37M Buy
34,891
+4,970
+17% +$485K 0.93% 46
2024
Q2 		$2.75M Buy
29,921
+60
+0.2% +$5.57K 0.92% 41
2024
Q1 		$2.75M Buy
29,861
+231
+0.8% +$21.6K 1% 44
2023
Q4 		$2.82M Buy
29,630
+3,490
+13% +$326K 1.09% 38
2023
Q3 		$2.44M Sell
26,140
-178
-0.7% -$16.4K 1.23% 32
2023
Q2 		$2.41M Buy
26,318
+18
+0.1% +$1.48K 1.14% 30
2023
Q1 		$1.93M Buy
26,300
+6,619
+34% +$573K 0.97% 44
2022
Q4 		$1.64M Sell
19,681
-134
-0.7% -$12.1K 0.84% 58
2022
Q3 		$1.92M Buy
19,815
+673
+4% +$80.3K 1.05% 37
2022
Q2 		$2.01M Sell
19,142
-33
-0.2% -$4.22K 1.06% 41
2022
Q1 		$3.3M Sell
19,175
-90
-0.5% -$13.4K 1.54% 17
2021
Q4 		$3.12M Buy
19,265
+6,096
+46% +$980K 1.29% 25
2021
Q3 		$1.96M Buy
13,169
+1,128
+9% +$234K 0.89% 59
2021
Q2 		$2.95M Sell
12,041
-393
-3% -$103K 1.01% 46
2021
Q1 		$3.29M Sell
12,434
-125
-1% -$35.3K 1.09% 42
2020
Q4 		$3.68M Sell
12,559
-130
-1% -$33.3K 1.4% 26
2020
Q3 		$3M Sell
12,689
-1,233
-9% -$280K 1.43% 23
2020
Q2 		$2.76M Sell
13,922
-6,381
-31% -$1.19M 1.27% 31
2020
Q1 		$3.73M Buy
20,303
+2,373
+13% +$422K 1.8% 10
2019
Q4 		$2.99M Buy
+17,930
New +$2.67M 1.23% 35

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bridge City Capital's AMED Position: Q3 2025 in Review

Bridge City Capital sold out of Amedisys (AMED) in Q3 2025, closing a stake of 34,455 shares — an estimated $3.39M sold.

Bridge City Capital first reported a position in AMED in Q4 2019 and held it in 23 quarters. The position peaked at $3.73M in Q1 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Bridge City Capital reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Bridge City Capital sold 34,455 Amedisys shares in Q3 2025, an estimated $3.39M.
  • Bridge City Capital first reported a position in Amedisys in Q4 2019 and held it in 23 quarters.
  • Bridge City Capital's Amedisys position peaked at $3.73M in Q1 2020.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Bridge City Capital's 13F filing for Q3 2025, filed 12 Nov 2025.